14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 ZNTL stock ended at $11.71. This is 5.40% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.76% from a day low at $11.45 to a day high of $12.11.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Zentalis Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Aug 23, 2023 $25.32 $25.97 $25.32 $25.69 294 583
Aug 22, 2023 $25.68 $25.79 $25.10 $25.32 259 053
Aug 21, 2023 $25.55 $25.80 $25.19 $25.49 329 889
Aug 18, 2023 $25.17 $26.05 $25.12 $25.71 315 023
Aug 17, 2023 $26.20 $26.20 $25.33 $25.48 369 170
Aug 16, 2023 $27.59 $27.79 $26.10 $26.31 657 275
Aug 15, 2023 $28.20 $28.47 $26.33 $27.64 646 739
Aug 14, 2023 $26.79 $29.03 $26.56 $28.25 779 353
Aug 11, 2023 $26.49 $27.08 $26.31 $27.06 287 269
Aug 10, 2023 $25.15 $27.00 $25.07 $26.74 512 556
Aug 09, 2023 $24.15 $25.78 $23.87 $25.58 594 146
Aug 08, 2023 $25.20 $25.86 $25.05 $25.40 365 503
Aug 07, 2023 $26.45 $26.45 $24.60 $25.19 537 825
Aug 04, 2023 $26.18 $26.58 $25.89 $26.28 232 846
Aug 03, 2023 $25.98 $26.65 $25.81 $26.13 369 963
Aug 02, 2023 $25.85 $26.15 $25.40 $26.11 433 924
Aug 01, 2023 $26.11 $26.32 $25.83 $26.25 273 237
Jul 31, 2023 $26.64 $27.02 $26.48 $26.71 259 802
Jul 28, 2023 $26.35 $27.26 $26.29 $26.74 428 866
Jul 27, 2023 $26.25 $26.25 $25.54 $26.09 597 242
Jul 26, 2023 $25.42 $25.96 $25.36 $25.92 322 432
Jul 25, 2023 $25.69 $25.92 $25.45 $25.59 213 445
Jul 24, 2023 $25.98 $26.38 $25.03 $25.68 352 877
Jul 21, 2023 $25.78 $26.26 $25.43 $26.19 306 023
Jul 20, 2023 $26.27 $26.36 $25.24 $25.65 437 389
Click to get the best stock tips daily for free!

About Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ... ZNTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT